Literature DB >> 30242102

Gabepentinoids and Benzodiazepines in Medicare Part D.

Eric D Weinhandl1.   

Abstract

Entities:  

Keywords:  gabapentin; pharmacoepidemiology; pregabalin

Mesh：

Substances：

Year:  2018        PMID： 30242102      PMCID： PMC6218855          DOI： 10.1681/ASN.2018070745

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  4 in total

1.  The effect of the Medicare Part D benzodiazepine exclusion on the utilization patterns of benzodiazepines and substitute medications.

Authors:  Yu-Chieh Chen; David H Kreling
Journal:  Res Social Adm Pharm       Date:  2013-07-21

2.  Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients.

Authors:  Julie H Ishida; Charles E McCulloch; Michael A Steinman; Barbara A Grimes; Kirsten L Johansen
Journal:  J Am Soc Nephrol       Date:  2018-06-05       Impact factor: 10.121

3.  Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients.

Authors:  Yi-Wen Chiu; Isaac Teitelbaum; Madhukar Misra; Essel Marie de Leon; Tochi Adzize; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 8.237

4.  Benzodiazepines and injurious falls in community dwelling elders.

Authors:  Antoine Pariente; Jean-Francois Dartigues; Jacques Benichou; Luc Letenneur; Nicholas Moore; Annie Fourrier-Réglat
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923
  4 in total
  1 in total

1.  Authors' Reply.

Authors:  Julie H Ishida; Charles E McCulloch; Michael A Steinman; Barbara A Grimes; Kirsten L Johansen
Journal:  J Am Soc Nephrol       Date:  2018-09-21       Impact factor: 10.121
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.